The Edwards Lifesciences Foundation has been a long-time supporter of the Fogarty Institute, investing a total of nearly half a million dollars since our inception. The organization recently awarded the Institute another grant that will go towards funding medical technology innovation and the Lefteroff internship programs, which support individuals and early-stage ideas designed to create the next generation of life sciences companies.
Edwards Lifesciences has also been the manufacturer of the Fogarty family of vascular products, which were innovated with Dr. Thomas Fogarty. These products are used in more than 300,000 procedures worldwide per year and are estimated to have saved the lives and limbs of 20 million patients.
“We are grateful to Edwards Lifesciences Foundation for its continued support and for sharing our passion to improve patient care,” said Ann Fyfe. “These funds will help our medical startups continue to develop their innovative technologies, projected to improve and/or save the lives of nearly 10 million people worldwide. They will also help us expand our thriving internship program, which provides invaluable real-world, on-the-job experience for young people who are just starting to explore the world of cardiac surgery and medical technology.”
“We are excited to partner with the Fogarty Institute to inspire new innovation in medical technology that will help underserved patients,” said Amanda C. Fowler, Executive Director, Global Corporate Giving of Edwards and Edwards Foundation. “As a convening point for global innovation, the Fogarty Institute is a strong partner for programs that inspire and guide students and startups that will create the next generation of devices seeking to lower healthcare costs and improve patients’ quality of life.”